SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31

Webcast is Live at 4:00 p.m. (CT)

Business Wire

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--

SurModics, Inc. (SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its third quarter 2013 conference call on Wednesday, July 31, at 4:00 p.m. CT (5:00 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, chief executive officer, and Andy LaFrence, vice president of finance and chief financial officer, will recap the third quarter 2013 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at www.surmodics.com the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7:00 p.m. CT on Wednesday, July 31, until 7:00 p.m. CT on Wednesday, August 7, and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4632073. In addition, the conference call audio and transcript will be archived on the Company’s website following the call.

About SurModics, Inc.

SurModics’ mission is to exceed our customers’ expectations and enhance patients’ well-being by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. SurModics partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit www.surmodics.com. The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

Contact:
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com

Rates

View Comments